Three-in-One Nanozyme for Radiosensitization of Bladder Cancer
In summary, this study highlights the potential of CPC nanozyme-mediated radiotherapy as a promising avenue for the effective treatment of bladder cancer and demonstrates its potential for future clinical applications in the synergistic therapy of bladder cancer.
Authors
- Na Feng (ORCID: https://orcid.org/0000-0001-6205-1960)
- Yuhan Zhang (ORCID: https://orcid.org/0009-0004-3328-2400)
- Bin Liu (ORCID: https://orcid.org/0000-0002-0956-2777)
- Yang Li (ORCID: https://orcid.org/0000-0002-4549-7087)
- Yu Fan
Institutions
- Union Hospital (HK)
- Nanfang Hospital (CN)
- Union Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- International Journal of Nanomedicine
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/ijn.s463242
- Citations
- 6
- Primary Topic
- Advanced Nanomaterials in Catalysis
- Type
- article
- Field-Weighted Citation Impact
- 0.70
Funders
- National Natural Science Foundation of China